Chinese english Germany Japanese Korea

1-methyl-8-(4-methylbenzyl)-7,8-dihydro-1H-imidazo[2,1-f]purine-2,4(3H,6H)-dione

1-methyl-8-(4-methylbenzyl)-7,8-dihydro-1H-imidazo[2,1-f]purine-2,4(3H,6H)-dione Struktur
303972-88-5
CAS-Nr.
303972-88-5
Englisch Name:
1-methyl-8-(4-methylbenzyl)-7,8-dihydro-1H-imidazo[2,1-f]purine-2,4(3H,6H)-dione
Synonyma:
1-methyl-8-(4-methylbenzyl)-7,8-dihydro-1H-imidazo[2,1-f]purine-2,4(3H,6H)-dione;1H-Imidazo[2,1-f]purine-2,4(3H,6H)-dione, 7,8-dihydro-1-methyl-8-[(4-methylphenyl)methyl]- (9CI);7-Methyl-1-(4-methyl-benzyl)-2,3-dihydro-1H,7H-1,3a,5,7,8-pentaaza-cyclopenta[a]indene-4,6-dione
CBNumber:
CB03785784
Summenformel:
C16H17N5O2
Molgewicht:
311.34
MOL-Datei:
303972-88-5.mol
Request For Quotation

1-methyl-8-(4-methylbenzyl)-7,8-dihydro-1H-imidazo[2,1-f]purine-2,4(3H,6H)-dione Eigenschaften

Dichte
1.47±0.1 g/cm3(Predicted)
pka
10.45±0.20(Predicted)

Sicherheit

1-methyl-8-(4-methylbenzyl)-7,8-dihydro-1H-imidazo[2,1-f]purine-2,4(3H,6H)-dione Chemische Eigenschaften,Einsatz,Produktion Methoden

1-methyl-8-(4-methylbenzyl)-7,8-dihydro-1H-imidazo[2,1-f]purine-2,4(3H,6H)-dione Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1-methyl-8-(4-methylbenzyl)-7,8-dihydro-1H-imidazo[2,1-f]purine-2,4(3H,6H)-dione Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6176 60
LIFE CHEMICALS, formerly I.F. Lab --
 vasily.pinchuk@lifechemicals.com Canada 6706 69
Princeton BioMolecular Research, Inc. --
 info@princetonbio.com United States 6934 51
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6349 50
  • 1-methyl-8-(4-methylbenzyl)-7,8-dihydro-1H-imidazo[2,1-f]purine-2,4(3H,6H)-dione
  • 7-Methyl-1-(4-methyl-benzyl)-2,3-dihydro-1H,7H-1,3a,5,7,8-pentaaza-cyclopenta[a]indene-4,6-dione
  • 1H-Imidazo[2,1-f]purine-2,4(3H,6H)-dione, 7,8-dihydro-1-methyl-8-[(4-methylphenyl)methyl]- (9CI)
  • 303972-88-5
Copyright 2019 © ChemicalBook. All rights reserved